- Home
- GNSS vs NVCT Comparison
GNSS vs NVCT Comparison
Compare GNSS & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNSS
- NVCT
- Stock Information
- Founded
- GNSS 1992
- NVCT 2020
- Country
- GNSS United States
- NVCT United States
- Employees
- GNSS N/A
- NVCT N/A
- Industry
- GNSS Consumer Electronics/Appliances
- NVCT Medicinal Chemicals and Botanical Products
- Sector
- GNSS Consumer Staples
- NVCT Health Care
- Exchange
- GNSS Nasdaq
- NVCT Nasdaq
- Market Cap
- GNSS 116.8M
- NVCT 107.8M
- IPO Year
- GNSS N/A
- NVCT 2022
- Fundamental
- Price
- GNSS $2.71
- NVCT $5.48
- Analyst Decision
- GNSS Strong Buy
- NVCT Strong Buy
- Analyst Count
- GNSS 3
- NVCT 1
- Target Price
- GNSS $5.33
- NVCT $21.00
- AVG Volume (30 Days)
- GNSS 182.0K
- NVCT 116.2K
- Earning Date
- GNSS 02-11-2025
- NVCT 03-04-2025
- Dividend Yield
- GNSS N/A
- NVCT N/A
- EPS Growth
- GNSS N/A
- NVCT N/A
- EPS
- GNSS N/A
- NVCT N/A
- Revenue
- GNSS $24,008,000.00
- NVCT N/A
- Revenue This Year
- GNSS $136.42
- NVCT N/A
- Revenue Next Year
- GNSS $56.53
- NVCT N/A
- P/E Ratio
- GNSS N/A
- NVCT N/A
- Revenue Growth
- GNSS N/A
- NVCT N/A
- 52 Week Low
- GNSS $1.51
- NVCT $4.44
- 52 Week High
- GNSS $4.04
- NVCT $12.10
- Technical
- Relative Strength Index (RSI)
- GNSS 38.98
- NVCT 52.08
- Support Level
- GNSS $2.57
- NVCT $5.46
- Resistance Level
- GNSS $2.81
- NVCT $5.89
- Average True Range (ATR)
- GNSS 0.17
- NVCT 0.52
- MACD
- GNSS 0.04
- NVCT 0.09
- Stochastic Oscillator
- GNSS 33.33
- NVCT 50.90
About GNSS Genasys Inc.
Genasys Inc is a provider of Protective Communication solutions, including Genasys Protect software platform and Long Range Acoustic Device (LRAD). Its software platform receives information from variety of sensors and Internet-of-Things (IoT) inputs to collect real-time information on developing and active emergency situations. Genasys uses this information to create and disseminate alerts, warnings, notifications, and instructions through multiple channels before, during, and after public safety and enterprise threats, critical events, and other crisis situations. The Company operates in two business segments: Hardware and Software and its markets are North and South America, Europe, Middle East and Asia. Key revenue is generated from Hardware.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.